Pa. Judge Explains Call To Keep $2.5M J&J Risperdal Verdict
A Pennsylvania state judge has explained his reason for denying a Johnson & Johnson unit's request for a new trial over abnormal breast growth allegedly linked to the drug Risperdal, saying...To view the full article, register now.
Already a subscriber? Click here to view full article